Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hidden Hills Club is a commercial-stage consumer health company specializing in the development and distribution of hemp-derived cannabinoid products. The company's portfolio focuses on alternative cannabinoids, including Delta-8 THC, Delta-11 THC, and THC-P, which are marketed for wellness and recreational applications. Their product line primarily consists of high-potency disposable vaporizers, cartridges, and infused edibles. Hidden Hills Club utilizes third-party laboratory testing to verify the potency and purity of its small molecule formulations. The brand is positioned within the lifestyle and wellness sector, targeting indications such as stress, anxiety, and sleep support. The company operates primarily within the United States, adhering to the legal standards established by the 2018 Farm Bill.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hidden Hills Club.